GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 15 filers reported holding GAIN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,929,985 | -21.2% | 588,410 | +7.7% | 0.11% | -4.3% |
Q2 2023 | $2,448,589 | -7.1% | 546,560 | 0.0% | 0.12% | -19.6% |
Q1 2023 | $2,634,419 | +54.0% | 546,560 | 0.0% | 0.14% | +21.2% |
Q4 2022 | $1,710,732 | -3.9% | 546,560 | 0.0% | 0.12% | -6.3% |
Q3 2022 | $1,781,000 | -9.5% | 546,560 | 0.0% | 0.13% | -17.6% |
Q2 2022 | $1,967,000 | -12.0% | 546,560 | 0.0% | 0.15% | +7.7% |
Q1 2022 | $2,236,000 | -24.7% | 546,560 | 0.0% | 0.14% | -16.5% |
Q4 2021 | $2,968,000 | -27.1% | 546,560 | 0.0% | 0.17% | -37.7% |
Q3 2021 | $4,069,000 | -25.6% | 546,560 | 0.0% | 0.27% | -20.4% |
Q2 2021 | $5,466,000 | -33.0% | 546,560 | 0.0% | 0.34% | -39.6% |
Q1 2021 | $8,155,000 | – | 546,560 | – | 0.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 30,293 | $303,000 | 0.42% |
Greenlight Capital | 546,560 | $5,466,000 | 0.34% |
CM Management, LLC | 10,000 | $100,000 | 0.07% |
Granite Point Capital Management, L.P. | 155,709 | $1,559,000 | 0.06% |
PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $581,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50,000 | $501,000 | 0.01% |
Banque Cantonale Vaudoise | 3,000 | $30,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 23,878 | $239,000 | 0.00% |
MORGAN STANLEY | 800 | $8,000 | 0.00% |
BlackRock Inc. | 11,659 | $116,000 | 0.00% |